Dr. Craig E. Devoe
Claim this profileNorthwell Health/Center for Advanced Medicine
Studies Rectal Cancer
Studies Colon Cancer
7 reported clinical trials
17 drugs studied
Area of expertise
1Rectal Cancer
ctDNA positive
NRAS positive
KRAS positive
2Colon Cancer
ctDNA positive
NRAS positive
KRAS positive
Affiliated Hospitals
Clinical Trials Craig E. Devoe is currently running
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting1 award Phase 2 & 3
Cabozantinib + Nivolumab
for Advanced Skin and Head & Neck Cancers
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine how quickly patients can be divided into groups based on biomarkers in their tumors. A biomarker is a biological molecule found in the blood, other body fluids, or in tissues that is a sign of a normal or abnormal process or a sign of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. The two biomarkers that this trial is studying are "tumor mutational burden" and "tumor inflammation signature." Another purpose of this trial is to help doctors learn if cabozantinib and nivolumab shrink or stabilize the cancer, and whether patients respond differently to the combination depending on the status of the biomarkers.
Recruiting1 award Phase 2
More about Craig E. Devoe
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Craig E. Devoe has experience with
- Irinotecan
- ELI-002
- ELI-002 7P
- Bevacizumab
- Cholecalciferol
- Fluorouracil
Breakdown of trials Craig E. Devoe has run
Rectal Cancer
Colon Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Craig E. Devoe specialize in?
Craig E. Devoe focuses on Rectal Cancer and Colon Cancer. In particular, much of their work with Rectal Cancer has involved ctDNA positive patients, or patients who are NRAS positive.
Is Craig E. Devoe currently recruiting for clinical trials?
Yes, Craig E. Devoe is currently recruiting for 2 clinical trials in Lake Success New York. If you're interested in participating, you should apply.
Are there any treatments that Craig E. Devoe has studied deeply?
Yes, Craig E. Devoe has studied treatments such as Irinotecan, ELI-002, ELI-002 7P.
What is the best way to schedule an appointment with Craig E. Devoe?
Apply for one of the trials that Craig E. Devoe is conducting.
What is the office address of Craig E. Devoe?
The office of Craig E. Devoe is located at: Northwell Health/Center for Advanced Medicine, Lake Success, New York 11042 United States. This is the address for their practice at the Northwell Health/Center for Advanced Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.